Coordinated circRNA Silencing and Chemotherapy by pH-Responsive Nanoparticles Reprogram Cell Death in Drug-Resistant Osteosarcoma
Nano Letters · 2026
DOI: 10.1021/acs.nanolett.6c02632 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, 2026. Verfasst von Xingkai Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Institute of Bone Tumor, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai200072, C…. Hauptthemen laut MEDLINE: Osteosarcoma, Drug Resistance, Neoplasm, Doxorubicin, RNA, Small Interfering. Die Arbeit nennt 68 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai Municipality, National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Chemoresistance remains a major clinical challenge in osteosarcoma, primarily driven by inefficient drug delivery and the evasion of cell death. Here, a multifunctional poly(β-amino ester) (pBAE)-based therapeutic delivery system was developed for simultaneous codelivery of small interfering RNA (siRNA) and doxorubicin (DOX) to drug-resistant osteosarcoma cells. The system significantly enhanced siRNA transfection within 4 h and showed substantially enhanced cytotoxicity compared with free DOX at equivalent concentrations. Mechanistically, pBAE degraded in the acidic tumor microenvironment, facilitating siRNA and DOX release, which synergistically modulated apoptotic and pyroptotic signaling to induce cell death. In vivo studies in osteosarcoma-bearing mice demonstrated that pBAE-based treatment markedly suppressed tumor growth, reducing tumor volume by approximately 70% without significant adverse effects. This study presents a therapeutic strategy centered on the “enhanced delivery-induced cell death” paradigm, effectively overcoming osteosarcoma chemoresistance and designing multifunctional nanodelivery systems for cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Institute of Bone Tumor, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai200072, China.
- Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, Shanghai201804, China.
- School of Materials Science and Engineering, East China University of Science and Technology, Shanghai200237, China.
ORCID-Profile: Caihong Chen, Chang Li, Jianzhong Du, Chunlin Zhang
Förderung
- Natural Science Foundation of Shanghai Municipality
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Program for Research-oriented Physician of Shanghai Tenth People?s Hospital
- Innovation Program of Shanghai Municipal Education Commission
Zitieren
APA
Wang, X., Chen, C., Ma, X., Tan, S., Zhu, K., Hu, J., Zhu, J., Li, C., Du, J., & Zhang, C. (2026). Coordinated circRNA Silencing and Chemotherapy by pH-Responsive Nanoparticles Reprogram Cell Death in Drug-Resistant Osteosarcoma. Nano Letters. https://doi.org/10.1021/acs.nanolett.6c02632
Vancouver
Wang X, Chen C, Ma X, Tan S, Zhu K, Hu J, et al. Coordinated circRNA Silencing and Chemotherapy by pH-Responsive Nanoparticles Reprogram Cell Death in Drug-Resistant Osteosarcoma. Nano Letters. 2026. doi:10.1021/acs.nanolett.6c02632
BibTeX
@article{Wang2026,
author = {Wang, Xingkai and Chen, Caihong and Ma, Xiaolong and Tan, Shuo and Zhu, Kunpeng and Hu, Jianping and Zhu, Jiazhuang and Li, Chang and Du, Jianzhong and Zhang, Chunlin},
title = {Coordinated circRNA Silencing and Chemotherapy by pH-Responsive Nanoparticles Reprogram Cell Death in Drug-Resistant Osteosarcoma},
journal = {Nano Letters},
year = {2026},
doi = {10.1021/acs.nanolett.6c02632}
}
EUVIMED